Wang WY - Search Results

1

New ent-kaurane diterpenoids with anti-platelet aggregation activity from Annona squamosa.

Yang YL, Chang FR, Wu CC, Wang WY, Wu YC. Yang YL, et al. Among authors: wang wy. J Nat Prod. 2002 Oct;65(10):1462-7. doi: 10.1021/np020191e. J Nat Prod. 2002. PMID: 12398544

2

Antiplatelet and anti-HIV constituents from Euchresta formosana.

Lo WL, Wu CC, Chang FR, Wang WY, Khalil AT, Lee KH, Wu YC. Lo WL, et al. Among authors: wang wy. Nat Prod Res. 2003 Apr;17(2):91-7. doi: 10.1080/1478641031000103669. Nat Prod Res. 2003. PMID: 12713120

3

Effect of active synthetic 2-substituted quinazolinones on anti-platelet aggregation and the inhibition of superoxide anion generation by neutrophils.

Chang FR, Wu CC, Hwang TL, Patnam R, Kuo RY, Wang WY, Lan YH, Wu YC. Chang FR, et al. Among authors: wang wy. Arch Pharm Res. 2003 Jul;26(7):511-5. doi: 10.1007/BF02976872. Arch Pharm Res. 2003. PMID: 12934640

4

Antiplatelet activity of benzylisoquinoline derivatives oxidized by cerium(IV) ammonium nitrate.

Kuo RY, Chang FR, Wu CC, Patnam R, Wang WY, Du YC, Wu YC. Kuo RY, et al. Among authors: wang wy. Bioorg Med Chem Lett. 2003 Aug 18;13(16):2789-93. doi: 10.1016/s0960-894x(03)00477-3. Bioorg Med Chem Lett. 2003. PMID: 12873516

5

Bioactive coumarins from the leaves of Murraya omphalocarpa.

Chen KS, Wu CC, Chang FR, Chia YC, Chiang MY, Wang WY, Wu YC. Chen KS, et al. Among authors: wang wy. Planta Med. 2003 Jul;69(7):654-7. doi: 10.1055/s-2003-41112. Planta Med. 2003. PMID: 12898423

6

Antiplatelet effects of KW-7, a new inhibitor of cyclic nucleotide phosphodiesterases.

Wu CC, Wang WY, Kuo RY, Chang FR, Wu YC. Wu CC, et al. Among authors: wang wy. Eur J Pharmacol. 2004 Jan 12;483(2-3):187-94. doi: 10.1016/j.ejphar.2003.10.046. Eur J Pharmacol. 2004. PMID: 14729106

7

2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.

Wu CC, Wang TW, Wang WY, Hsieh PW, Wu YC. Wu CC, et al. Among authors: wang wy, wang tw. Eur J Pharmacol. 2005 Dec 19;527(1-3):37-43. doi: 10.1016/j.ejphar.2005.10.023. Epub 2005 Nov 28. Eur J Pharmacol. 2005. PMID: 16313903

8

Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.

Wang WY, Wu YC, Wu CC. Wang WY, et al. Mol Pharmacol. 2006 Oct;70(4):1380-9. doi: 10.1124/mol.106.023986. Epub 2006 Jul 12. Mol Pharmacol. 2006. PMID: 16837624

9

Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins.

Wu CC, Wu CI, Wang WY, Wu YC. Wu CC, et al. Among authors: wang wy. Planta Med. 2007 May;73(5):439-43. doi: 10.1055/s-2007-967173. Planta Med. 2007. PMID: 17566146

10

Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.

Wang WY, Hsieh PW, Wu YC, Wu CC. Wang WY, et al. Biochem Pharmacol. 2007 Aug 15;74(4):601-11. doi: 10.1016/j.bcp.2007.06.001. Epub 2007 Jun 3. Biochem Pharmacol. 2007. PMID: 17601492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,177 results

Search Page

Filters